Humanized Mouse Model Market Growing at a CAGR of 9.6% During 2016 to 2021

Friday, January 27, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, January 27, 2017 /PRNewswire/ --

The global humanized mouse model market is projected to reach

USD 116.0 million by 2021 from USD 73.3 million in 2016, growing at a CAGR of 9.6% in the next five years (2016 to 2021) propelled by increase in R&D activities carried out by pharmaceutical and biotechnology

Browse 69 tables and 47 figures, 12 Company profiles spread across 182 pages available at .

Growing adoption of personalized medicine to fuel the demand for personalized mice models, continuous support in the form of investments and grants from the government and private sectors, and increase in R&D activities carried out by pharmaceutical and biotechnology companies are the key factors driving the growth of the market. However, regulations & laws formulated for ethical use of animals and increased use of rat models are restraining the growth of the market to a certain extent.  

The global humanized mouse model market is segmented on the basis of type, application, end user, and region. In 2016, North America is expected to account for the largest share of the global humanized mouse model market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is projected to have the highest growth rate in the forecast period. The high growth rate of this segment can be attributed to factors such as increasing investments from the government and private sector in China, growing biomedical and medical research industry in Japan, growing presence of global players in India, and increasing pharmaceutical and biotech R&D activities in Korea.

Key players in the global humanized mouse model market include The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Harbour Antibodies BV (China), HuMurine Technologies, Inc. (U.S.), Vitalstar Biotechnology Co. Ltd. (China), Crown Bioscience, Inc. (U.S.), ingenious targeting laboratory (U.S.), Axenis S.A.S (France), TRANSGENIC, Inc. (Japan), genOway S.A. (France), and Horizon Discovery Group plc (U.K.). Order a copy of Humanized Mouse Model Market by Type (Genetic, Cell-based (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoiesis, Oncology, Immunology & Infectious diseases) & End User(Pharmaceutical & Biotech Companies, CRO)) - Global Forecast to 2021 research report at .

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (product launches, collaborations, agreements, partnerships, alliances, grants, licensing, contracts, acquisitions, and expansions) to increase their market shares and establish a strong foothold in the global market.   

Related Reports: 

  • Knock out Mouse Model- Pricing Analysis, [by Indication, Mouse type, End users, Discounting, Corporate Agreements, Economic Model of Demand and Supply, Physiological Characteristics, Business Models, and Stakeholder Analysis]
  • Rat Model Market by Model Type (Outbred, Inbred, Knockout), Technology (CRISPR, Micro Injection), Therapeutic Area (Neurology, Oncology), Service (Breeding, Cryopreservation), Care Products (Cages, Feed, Bedding) & End User -Global Forecast to 2021
  • Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020

Explore more reports on biotechnology market at

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact: Ritesh Tiwari 2nd Floor, Metropole Building, Next to Inox Theatre, Bund Garden Road, Pune - 411013. Maharashtra, India. + 1 888 391 5441

Connect with Us:  LinkedIn: RSS/Feeds: http://

SOURCE ReportsnReports


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store